Covaxin's phase 3 results soons, says Bharat Biotech

Bharat Biotech on Saturday said scientific standards and commitment of the indigenously-developed COVID-19 vaccine Covaxin are transparent, and the company has so far published nine research studies on its safety and efficacy.

from IndiaTV: Google News Feed https://ift.tt/3cDxUH0